Jibe Therapeutics is developing a next-generation cancer treatment that helps the immune system better recognize and attack tumors. As a result of its "Golden Ticket" pitch competition win, Jibe is relocating its research operations to Dallas' Pegasus Park.
The gift, the largest to date for BrightEdge, will fund a "first-of-its-kind program" called the ACS BrightEdge Texas Accelerator. The two-year pilot innovation program will invest in cutting-edge companies making headway in the fight to eliminate cancer.
Ireland-based H&MV Engineering planted its North American headquarters in Dallas. The move is part of a push to create 1,000 new U.S. jobs and reach $3.5 billion in revenue over the next five years....
The Colossal Foundation and the IUCN Species Survival Commission launched a four-year, $4 million partnership to accelerate species conservation. The foundation is the nonprofit arm of Dallas-based de-extinction company Colossal Biosciences....
Ireland-based H&MV Engineering planted its North American headquarters in Dallas. The move is part of a push to create 1,000 new U.S. jobs and reach $3.5 billion in revenue over the next five years....
The Colossal Foundation and the IUCN Species Survival Commission launched a four-year, $4 million partnership to accelerate species conservation. The foundation is the nonprofit arm of Dallas-based de-extinction company Colossal Biosciences....